ABN AMRO Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Buy |
+177,707
| New | +$14M | 0.18% | 61 |
|
|
2025
Q1 | – | Sell |
-175,220
| Closed | -$12.8M | – | 164 |
|
|
2024
Q4 | $12.8M | Buy |
175,220
+2,017
| +1% | +$148K | 0.17% | 60 |
|
|
2024
Q3 | $11.3M | Sell |
173,203
-374
| -0.2% | -$24.5K | 0.16% | 66 |
|
|
2024
Q2 | $16.2M | Sell |
173,577
-2,106
| -1% | -$196K | 0.24% | 53 |
|
|
2024
Q1 | $16.8M | Buy |
175,683
+6,229
| +4% | +$596K | 0.25% | 52 |
|
|
2023
Q4 | $13M | Buy |
169,454
+30,849
| +22% | +$2.37M | 0.21% | 56 |
|
|
2023
Q3 | $9.6M | Buy |
138,605
+3,067
| +2% | +$212K | 0.17% | 60 |
|
|
2023
Q2 | $12.9M | Sell |
135,538
-5,338
| -4% | -$506K | 0.26% | 41 |
|
|
2023
Q1 | $11.7M | Buy |
+140,876
| New | +$11.7M | 0.26% | 39 |
|